ENTITY

Sage Therapeutics (SAGE US)

21
Analysis
Health Care • United States
Sage Therapeutics, Inc. develops treatments for central nervous system disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Sage Therapeutics operates in the United States.
more
bullish•Sage Therapeutics
•24 Feb 2025 12:07•Podcast

Yet Another Value's special situation: Sage Therapeutics $SAGE

The podcast episode explores the impact of passive investing on corporate governance, potential investment opportunities in Full House Resorts (FL)...

Share
bullish•S&P 500 INDEX
•05 Oct 2022 04:20

Another Bear Market Rally Brewing?; Stick With Biotech and Construction/Engineering Names

Early indications suggest another bear market rally in $SPX, and potentially that the lows are in, helped by short-term bearish engulfing patterns...

Logo
410 Views
Share
bullish•S&P 500 INDEX
•10 Aug 2022 06:18

S&P 500, Nasdaq 100 Testing Key Resistance Levels; Pause Likely; Buying Biotech

$SPX is testing important resistance in the 4165-4180 area, the same resistance level we were monitoring in early June before the market tumbled 13...

Logo
438 Views
Share
bullish•S&P 500 INDEX
•06 Mar 2019 06:17

S&P 500 and S&P 600 Testing Resistance...Still

The S&P 500 is beginning to come off of short-term overbought extremes, consolidating near the confluence of key overhead resistance and the...

Logo
295 Views
Share
bullish•Shionogi & Co
•22 Jun 2018 18:30

Innovation to Help Maintain HIV Franchise Market Share and Weather Harsh Domestic Market Conditions

Continuous innovation at HIV Franchise to not only help defend market share…. Concerns about competition from Gilead Sciences Inc (GILD US)'s,...

x